NCT01851369 2024-05-08
TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
Clinical Trials
1 trialsPhase 1/2 × atropine sulfate-diphenoxylate hydrochloride drug combination × Gastrointestinal × Clear all